CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 162 filers reported holding CLOVIS ONCOLOGY INC in Q4 2019. The put-call ratio across all filers is 1.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $5,861,000 | -76.1% | 1,491,376 | -9.5% | 0.22% | -76.7% |
| Q2 2019 | $24,507,000 | -29.4% | 1,648,090 | +17.9% | 0.95% | -32.2% |
| Q1 2019 | $34,706,000 | +222.1% | 1,398,300 | +133.0% | 1.40% | +316.0% |
| Q4 2018 | $10,776,000 | -83.7% | 600,000 | -38.4% | 0.34% | -84.4% |
| Q4 2017 | $66,221,000 | +24.1% | 973,840 | +50.4% | 2.16% | +20.5% |
| Q3 2017 | $53,347,000 | -4.5% | 647,420 | +8.6% | 1.79% | -11.3% |
| Q2 2017 | $55,832,000 | +192.3% | 596,300 | +98.8% | 2.02% | +130.0% |
| Q1 2017 | $19,101,000 | -31.2% | 300,000 | -52.0% | 0.88% | -44.2% |
| Q4 2016 | $27,763,000 | +10.0% | 625,000 | -10.7% | 1.57% | +2.0% |
| Q3 2016 | $25,235,000 | -30.6% | 700,000 | -73.6% | 1.54% | -22.4% |
| Q2 2016 | $36,358,000 | -5.3% | 2,650,000 | +32.5% | 1.98% | -8.9% |
| Q1 2016 | $38,400,000 | -28.1% | 2,000,000 | +31.1% | 2.18% | -32.9% |
| Q4 2015 | $53,375,000 | +62.2% | 1,525,000 | +221.1% | 3.24% | +63.8% |
| Q1 2014 | $32,903,000 | +453.9% | 475,000 | +381.9% | 1.98% | +448.2% |
| Q4 2013 | $5,940,000 | -61.8% | 98,563 | -61.5% | 0.36% | -56.7% |
| Q3 2013 | $15,566,000 | +85.9% | 256,021 | +104.8% | 0.83% | +64.8% |
| Q2 2013 | $8,373,000 | – | 125,000 | – | 0.51% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 814,833 | $45,630,648,000 | 43.63% |
| EcoR1 Capital, LLC | 384,348 | $21,523,000 | 10.89% |
| Palo Alto Investors LP | 2,102,857 | $117,760,000 | 6.91% |
| NEA Management Company, LLC | 2,279,781 | $127,668,000 | 6.19% |
| Redmile Group, LLC | 721,632 | $40,411,000 | 4.40% |
| Opaleye Management Inc. | 140,000 | $7,840,000 | 3.96% |
| CLIFTON PARK CAPITAL MANAGEMENT, LLC | 790,555 | $44,271,000 | 2.63% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 339,327 | $19,002,000 | 2.31% |
| PFM Health Sciences, LP | 1,725,126 | $96,607,000 | 2.26% |
| HARBOURVEST PARTNERS LLC | 51,037 | $2,858,000 | 1.50% |